Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica M Richards

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Translational Neuroscience|December 3, 2013
NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDERDaniel C Mathews, Erica M Richards, Mark J Niciu, et al.
Acta Neuropsychiatrica|January 21, 2015
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalographyDawn F Ionescu, Allison C Nugent, David A Luckenbaugh, et al.
Journal of Affective Disorders|April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
Depression and Anxiety|December 20, 2013
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressantsMark J Niciu, Daniel C Mathews, Allison C Nugent, et al.
The Journal of Clinical Psychiatry|October 9, 2014
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamineDawn F Ionescu, David A Luckenbaugh, Mark J Niciu, et al.
The Journal of Clinical Psychiatry|June 13, 2014
Clinical predictors of ketamine response in treatment-resistant major depressionMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 11, 2015
Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigationNíall Lally, Li An, Dipavo Banerjee, et al.
Journal of Psychiatric Research|August 1, 2015
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressantElizabeth D Ballard, David A Luckenbaugh, Erica M Richards, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
The International Journal of Neuropsychopharmacology|December 25, 2014
Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorderMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Translational Neuroscience|December 3, 2013
NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDERDaniel C Mathews, Erica M Richards, Mark J Niciu, et al.
Acta Neuropsychiatrica|January 21, 2015
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalographyDawn F Ionescu, Allison C Nugent, David A Luckenbaugh, et al.
Journal of Affective Disorders|April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
Depression and Anxiety|December 20, 2013
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressantsMark J Niciu, Daniel C Mathews, Allison C Nugent, et al.
The Journal of Clinical Psychiatry|October 9, 2014
Effect of baseline anxious depression on initial and sustained antidepressant response to ketamineDawn F Ionescu, David A Luckenbaugh, Mark J Niciu, et al.
The Journal of Clinical Psychiatry|June 13, 2014
Clinical predictors of ketamine response in treatment-resistant major depressionMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 11, 2015
Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigationNíall Lally, Li An, Dipavo Banerjee, et al.
Journal of Psychiatric Research|August 1, 2015
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressantElizabeth D Ballard, David A Luckenbaugh, Erica M Richards, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
The International Journal of Neuropsychopharmacology|December 25, 2014
Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorderMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.
Pageof 3